Ligand Pharmaceuticals, Inc. (LGND)

195.83 -1.31 (-0.66%) USD  |  NASDAQ  |  Dec 26, 16:00
194.36 -1.47 (-0.75%) Pre-Market: 20:00
More

Ligand Pharmaceuticals Amortization Expense CF (% of Quarterly Assets)

Amortization Expense CF (% of Quarterly Assets) Chart

View Amortization Expense CF (% of Quarterly Assets) for LGND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Amortization Expense CF (% of Quarterly Assets) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years

View Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Amortization Expense CF (% of Quarterly Assets) Benchmarks

View Amortization Expense CF (% of Quarterly Assets) Benchmarks
Start Trial
Merck & Co., Inc. Upgrade
Johnson & Johnson Upgrade
Inspire Medical Systems, Inc. --
Elanco Animal Health, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. --